Jason Butler
Stock Analyst at Citizens JMP
(4.83)
# 449
Out of 4,673 analysts
718
Total ratings
52%
Success rate
19.2%
Average return
Main Sectors:
Stocks Rated by Jason Butler
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ARGX argenx SE | Maintained: Buy | $932 → $1,200 | $1,039.78 | +15.41% | 44 | Aug 18, 2026 | |
| LONA LeonaBio | Maintained: Buy | $18 → $17 | $7.69 | +121.21% | 36 | Aug 17, 2026 | |
| CYTK Cytokinetics | Maintained: Buy | $96 → $110 | $76.84 | +43.15% | 63 | Aug 7, 2026 | |
| HALO Halozyme Therapeutics | Maintained: Buy | $92 → $93 | $108.17 | -14.02% | 49 | Aug 7, 2026 | |
| ZVRA Zevra Therapeutics | Maintained: Buy | $25 → $28 | $11.87 | +135.89% | 11 | Aug 6, 2026 | |
| ACAD ACADIA Pharmaceuticals | Maintained: Buy | $35 → $36 | $29.50 | +22.03% | 49 | Aug 5, 2026 | |
| RZLT Rezolute | Upgraded: Buy | $11 | $5.09 | +116.11% | 33 | Jun 3, 2026 | |
| ABVX ABIVAX Société Anonyme | Maintained: Buy | $131 → $187 | $114.95 | +62.68% | 14 | Jun 2, 2026 | |
| GHRS GH Research | Maintained: Buy | $42 → $39 | $28.33 | +37.66% | 24 | May 15, 2026 | |
| PGEN Precigen | Maintained: Buy | $9 → $11 | $7.20 | +52.78% | 49 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $62 → $55 | $19.83 | +177.36% | 3 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $19 → $20 | $9.45 | +111.64% | 27 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $14 | $4.84 | +189.26% | 19 | Apr 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $19 → $18 | $4.00 | +350.00% | 2 | Mar 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 → $10 | $4.29 | +133.10% | 19 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $19 | $7.99 | +137.80% | 1 | Nov 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $77 → $80 | $48.24 | +65.84% | 6 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $9 → $12 | $4.66 | +157.51% | 53 | Oct 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $19 → $22 | $8.20 | +168.29% | 43 | Sep 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $42 → $38 | $24.29 | n/a | 29 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.001 | n/a | 38 | Dec 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0001 | n/a | 31 | Dec 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.1952 | n/a | 13 | Nov 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $33.93 | n/a | 8 | Jun 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $5.57 | n/a | 9 | Apr 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.000001 | n/a | 5 | Sep 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $2.80 | n/a | 5 | Aug 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €360.21 | €894.30 | n/a | 1 | Feb 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $58 → $70 | $87.02 | n/a | 3 | Jan 9, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $4.18 | n/a | 7 | Sep 5, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $3.85 | n/a | 3 | Mar 28, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $52 | $5.28 | n/a | 8 | Feb 14, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $17 | $3.00 | n/a | 1 | Oct 18, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $61 | $291.89 | n/a | 1 | Jul 28, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $4.15 | n/a | 5 | May 10, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 → $2 | $42.68 | n/a | 2 | Aug 16, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $15.46 | n/a | 1 | May 22, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $17.14 | n/a | 2 | May 6, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $1.76 | n/a | 1 | Mar 26, 2013 |
argenx SE
Aug 18, 2026
Maintained: Buy
Price Target: $932 → $1,200
Current: $1,039.78
Upside: +15.41%
LeonaBio
Aug 17, 2026
Maintained: Buy
Price Target: $18 → $17
Current: $7.69
Upside: +121.21%
Cytokinetics
Aug 7, 2026
Maintained: Buy
Price Target: $96 → $110
Current: $76.84
Upside: +43.15%
Halozyme Therapeutics
Aug 7, 2026
Maintained: Buy
Price Target: $92 → $93
Current: $108.17
Upside: -14.02%
Zevra Therapeutics
Aug 6, 2026
Maintained: Buy
Price Target: $25 → $28
Current: $11.87
Upside: +135.89%
ACADIA Pharmaceuticals
Aug 5, 2026
Maintained: Buy
Price Target: $35 → $36
Current: $29.50
Upside: +22.03%
Rezolute
Jun 3, 2026
Upgraded: Buy
Price Target: $11
Current: $5.09
Upside: +116.11%
ABIVAX Société Anonyme
Jun 2, 2026
Maintained: Buy
Price Target: $131 → $187
Current: $114.95
Upside: +62.68%
GH Research
May 15, 2026
Maintained: Buy
Price Target: $42 → $39
Current: $28.33
Upside: +37.66%
Precigen
May 14, 2026
Maintained: Buy
Price Target: $9 → $11
Current: $7.20
Upside: +52.78%
May 14, 2026
Maintained: Buy
Price Target: $62 → $55
Current: $19.83
Upside: +177.36%
May 8, 2026
Maintained: Buy
Price Target: $19 → $20
Current: $9.45
Upside: +111.64%
Apr 15, 2026
Initiated Coverage: Buy
Price Target: $14
Current: $4.84
Upside: +189.26%
Mar 26, 2026
Maintained: Buy
Price Target: $19 → $18
Current: $4.00
Upside: +350.00%
Feb 26, 2026
Maintained: Buy
Price Target: $8 → $10
Current: $4.29
Upside: +133.10%
Nov 25, 2025
Initiated Coverage: Buy
Price Target: $19
Current: $7.99
Upside: +137.80%
Nov 7, 2025
Maintained: Buy
Price Target: $77 → $80
Current: $48.24
Upside: +65.84%
Oct 9, 2025
Maintained: Buy
Price Target: $9 → $12
Current: $4.66
Upside: +157.51%
Sep 9, 2025
Reiterated: Buy
Price Target: $19 → $22
Current: $8.20
Upside: +168.29%
May 7, 2025
Maintained: Buy
Price Target: $42 → $38
Current: $24.29
Upside: n/a
Dec 27, 2024
Downgraded: Hold
Price Target: n/a
Current: $0.001
Upside: n/a
Dec 27, 2024
Rated: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
Nov 3, 2023
Rated: Hold
Price Target: n/a
Current: $0.1952
Upside: n/a
Jun 9, 2023
Rated: Hold
Price Target: n/a
Current: $33.93
Upside: n/a
Apr 6, 2023
Rated: Hold
Price Target: n/a
Current: $5.57
Upside: n/a
Sep 3, 2021
Rated: Hold
Price Target: n/a
Current: $0.000001
Upside: n/a
Aug 16, 2021
Reiterated: Hold
Price Target: n/a
Current: $2.80
Upside: n/a
Feb 1, 2021
Maintained: Buy
Price Target: €360.21
Current: €894.30
Upside: n/a
Jan 9, 2020
Maintained: Buy
Price Target: $58 → $70
Current: $87.02
Upside: n/a
Sep 5, 2019
Downgraded: Hold
Price Target: n/a
Current: $4.18
Upside: n/a
Mar 28, 2019
Downgraded: Hold
Price Target: n/a
Current: $3.85
Upside: n/a
Feb 14, 2019
Reiterated: Buy
Price Target: $52
Current: $5.28
Upside: n/a
Oct 18, 2016
Reiterated: Buy
Price Target: $17
Current: $3.00
Upside: n/a
Jul 28, 2016
Reiterated: Buy
Price Target: $61
Current: $291.89
Upside: n/a
May 10, 2016
Reiterated: Hold
Price Target: n/a
Current: $4.15
Upside: n/a
Aug 16, 2013
Reiterated: Buy
Price Target: $6 → $2
Current: $42.68
Upside: n/a
May 22, 2013
Initiated Coverage: Hold
Price Target: n/a
Current: $15.46
Upside: n/a
May 6, 2013
Downgraded: Hold
Price Target: n/a
Current: $17.14
Upside: n/a
Mar 26, 2013
Downgraded: Hold
Price Target: n/a
Current: $1.76
Upside: n/a